OR27-04 Efficacy And Safety Results From The Randomized, Placebo-controlled Multicenter Trial With Teprotumumab In Chronic-Low Clinical Activity Score Thyroid Eye Disease Patients

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10554583 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature